Martingale Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$271K Buy
21,125
+29
+0.1% +$236 0.01% 763
2026
Q2
$209K Hold
21,096
– – 0.01% 813
2026
Q1
$129K Buy
+21,096
New +$175K ﹤0.01% 787

Other funds holding DNA

Martingale Asset Management's DNA Position: Q3 2026 in Review

Martingale Asset Management increased its Ginkgo Bioworks (DNA) stake by 0.14% in Q3 2026, buying an estimated $236 and bringing the position to 21,125 shares worth $271K. The position accounts for 0.01% of the portfolio, ranked #763.

Martingale Asset Management first reported a position in DNA in Q1 2026 and has held it in 3 quarters since. 185 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Martingale Asset Management held 21,125 shares of Ginkgo Bioworks worth $271K as of Q3 2026.
  • Martingale Asset Management bought 29 Ginkgo Bioworks shares in Q3 2026, an estimated $236.
  • Ginkgo Bioworks made up 0.01% of Martingale Asset Management's portfolio in Q3 2026, its #763 holding.
  • Martingale Asset Management first reported a position in Ginkgo Bioworks in Q1 2026 and has held it in 3 quarters since.
  • 185 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Martingale Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.